Skip to main content
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
6.04
-0.06 (-0.98%)
At close: Dec 5, 2025, 4:00 PM EST
6.21
+0.17 (2.81%)
After-hours: Dec 5, 2025, 4:10 PM EST

Champions Oncology Revenue

Champions Oncology had revenue of $14.00M in the quarter ending July 31, 2025, a decrease of -0.47%. This brings the company's revenue in the last twelve months to $56.88M, up 10.11% year-over-year. In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth.

Revenue (ttm)
$56.88M
Revenue Growth
+10.11%
P/S Ratio
1.46
Revenue / Employee
$267,033
Employees
213
Market Cap
83.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

CSBR News

More News